PGIM India Healthcare Fund - Direct Plan - Growth Option
PGIM India Asset Management Private Limited · Direct Plan · Growth
Fund overview
0.50% on or before 90D, Nil after 90D
Returns & rankings
| Period | Fund Returns | Category Avg. | Rank | VS Category |
|---|---|---|---|---|
| … | ||||
Green = fund outperformed the category average for that period; red = underperformed. Periods under 1 year always show absolute (non-annualised) returns. Past performance does not guarantee future returns.
Return calculator
One-time investment
₹5,000
| Over the past | Total investment | Would've become | Returns |
|---|---|---|---|
| 1 Year | ₹5,000 | ₹5,412 | +412 |
| 3 Years | ₹5,000 | ₹6,339 | +1,339 |
| 5 Years | ₹5,000 | ₹7,425 | +2,425 |
Calculated using the fund's annualised return since inception (8.2% p.a.) as period-wise historical returns aren't available in the current feed. Actual returns fluctuate and are not guaranteed. Mutual fund investments are subject to market risks.
Holdings
31 securitiesTop 10 holdings make up 56.1% of the portfolio.
| Security | Sector | Market Cap | Weight |
|---|---|---|---|
| Divi'S Laboratories Ltd | Pharmaceuticals & Biotechnology | Large Cap | 10.36% |
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals & Biotechnology | Large Cap | 10.25% |
| Torrent Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Large Cap | 8.49% |
| Clearing Corporation of India Ltd. | Cash/Deposits/Margins/Treps/Repo/Swaps | — | 5.24% |
| Ajanta Pharma Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 4.96% |
| Max Healthcare Institute Ltd | Healthcare Services | Mid Cap | 4.71% |
| Dr. Lal Pathlabs Ltd | Healthcare Services | Small Cap | 4.33% |
| Mankind Pharma Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 4.04% |
| Manipal Health Enterprises Ltd | Healthcare Services | Mid Cap | 3.68% |
| Navin Fluorine International Ltd | Chemicals & Petrochemicals | Small Cap | 3.24% |
Portfolio Allocation
Equity / Debt / Cash
Total Value
₹130 Cr
Market Cap Split
Total Value
100%
Equity sector allocation
Total Value
₹124 Cr
Exit load, stamp duty & tax
06-Dec-24
0.50% on or before 90D, Nil after 90D
0.005% (from July 1st, 2020)
Taxation depends on the fund category and holding period. Consult the scheme document or a tax advisor for details.
Risk & Performance Ratios (1Y)
| Standard Deviation | -- |
| Beta | -- |
| Sharpe Ratio | -- |
| Sortino Ratio | -- |
| Treynor Ratio | -- |
| Jensen's Alpha | -- |
| Information Ratio | -- |
| R-Squared | -- |
| Max Drawdown | -- |
| Upside Capture | -- |
| Downside Capture | -- |
Fund management
Scheme Details
Investment objective
The Primary Investment Objective Of The Scheme Is To Seek To Generate Consistent Returns By Predominantly Investing In Equity And Equity Related Securities Of Pharmaceutical And Healthcare Companies.
Fund house
PGIM India Asset Management Private Limited
Frequently asked questions
What is the NAV of PGIM India Healthcare Fund - Direct Plan - Growth Option?
The NAV of PGIM India Healthcare Fund - Direct Plan - Growth Option is ₹11.60 as of 21 Oct 2026. NAV is updated at the end of every trading day.
How much expense ratio is charged by PGIM India Healthcare Fund - Direct Plan - Growth Option?
The expense ratio charged by PGIM India Healthcare Fund - Direct Plan - Growth Option is 0.96%.
What is the Min. SIP of PGIM India Healthcare Fund - Direct Plan - Growth Option?
The minimum SIP investment in PGIM India Healthcare Fund - Direct Plan - Growth Option is ₹1,000 per month.
What is the Min. Lumpsum of PGIM India Healthcare Fund - Direct Plan - Growth Option?
The minimum lumpsum investment in PGIM India Healthcare Fund - Direct Plan - Growth Option is ₹5,000.
What is the Exit Load of PGIM India Healthcare Fund - Direct Plan - Growth Option?
The exit load for PGIM India Healthcare Fund - Direct Plan - Growth Option is: 0.50% on or before 90D, Nil after 90D
.svg){kind=small}